https://www.selleckchem.com/products/OSI-906.html
Modified ultrafiltration (MUF) is still used after pediatric cardiopulmonary bypass (CP in some pediatric cardiac surgery centers to decrease transfusion requirements. Other potential benefits of MUF include clearance of inflammatory markers and improvement in myocardial function. Our hypothesis is that MUF will hemoconcentrate coagulation factors and improve thromboelastography (TEG) parameters after pediatric CPB. Patients younger than 6 months were prospectively enrolled over a year. TEG was carried out before MUF, after MUF, and a
Like
Comment
Share
